Toward Routine CSP of Pharmaceuticals: A Fully Automated Protocol Using Neural Network Potentials

• URL: http://arxiv.org/abs/2507.16218v1
• Date: Tue, 22 Jul 2025 04:26:16 GMT
• Title: Toward Routine CSP of Pharmaceuticals: A Fully Automated Protocol Using Neural Network Potentials
• Abstract summary: Crystal structure prediction (CSP) is a useful tool in pharmaceutical development for identifying and assessing risks associated with polymorphism.<n>Here, we introduce a fully automated, high- throughput CSP protocol designed to overcome these barriers.<n>The protocol's efficiency is driven by Lavo-NN, a novel neural network potential (NNP) architected and trained specifically for pharmaceutical crystal structure generation and ranking.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Crystal structure prediction (CSP) is a useful tool in pharmaceutical development for identifying and assessing risks associated with polymorphism, yet widespread adoption has been hindered by high computational costs and the need for both manual specification and expert knowledge to achieve useful results. Here, we introduce a fully automated, high-throughput CSP protocol designed to overcome these barriers. The protocol's efficiency is driven by Lavo-NN, a novel neural network potential (NNP) architected and trained specifically for pharmaceutical crystal structure generation and ranking. This NNP-driven crystal generation phase is integrated into a scalable cloud-based workflow. We validate this CSP protocol on an extensive retrospective benchmark of 49 unique molecules, almost all of which are drug-like, successfully generating structures that match all 110 $Z' = 1$ experimental polymorphs. The average CSP in this benchmark is performed with approximately 8.4k CPU hours, which is a significant reduction compared to other protocols. The practical utility of the protocol is further demonstrated through case studies that resolve ambiguities in experimental data and a semi-blinded challenge that successfully identifies and ranks polymorphs of three modern drugs from powder X-ray diffraction patterns alone. By significantly reducing the required time and cost, the protocol enables CSP to be routinely deployed earlier in the drug discovery pipeline, such as during lead optimization. Rapid turnaround times and high throughput also enable CSP that can be run in parallel with experimental screening, providing chemists with real-time insights to guide their work in the lab.

Related papers

• Bridging the NISQ and Fault-Tolerant Regimes: Generative-ML-Assisted Quantum Selected CI for Molecular Simulations [0.0]
  This report presents a hybrid quantum-classical workflow performed on the Fujitsu FX700.<n>It addresses two structural inefficiencies in quantum-based diagonalization.<n>It enables more efficient and economical drug discovery simulations for the industry.
  arXiv  Detail & Related papers  (2026-06-29T16:48:44Z)
• Towards a Virtual Neuroscientist: Autonomous Neuroimaging Analysis via Multi-Agent Collaboration [53.772014300855375]
  We introduce NIAgent, a multi-agent system for autonomous end-to-end neuroimaging analysis.<n>Unlike conventional flat tool-calling agents, NIAgent adopts a code-centric execution paradigm.<n>We propose a hierarchical verification framework for autonomous quality control, integrating cohort-level metric screening with agentic visual inspection.
  arXiv  Detail & Related papers  (2026-05-10T06:30:19Z)
• From Static Spectra to Operando Infrared Dynamics: Physics Informed Flow Modeling and a Benchmark [67.29937933325849]
  Operando IR Prediction aims to forecast the time-resolved evolution of spectral fingerprints'' from a single static spectrum.<n>OpIRSpec-7K comprises 7,118 high-quality samples across 10 distinct battery systems.<n>ABCC significantly outperforms state-of-the-art static, sequential, and generative baselines.
  arXiv  Detail & Related papers  (2026-02-20T18:58:43Z)
• Predictive Feature Caching for Training-free Acceleration of Molecular Geometry Generation [67.20779609022108]
  Flow matching models generate high-fidelity molecular geometries but incur significant computational costs during inference.<n>This work discusses a training-free caching strategy that accelerates molecular geometry generation.<n> Experiments on the GEOM-Drugs dataset demonstrate that caching achieves a twofold reduction in wall-clock inference time.
  arXiv  Detail & Related papers  (2025-10-06T09:49:14Z)
• FastCSP: Accelerated Molecular Crystal Structure Prediction with Universal Model for Atoms [21.170799561884035]
  FastCSP is an open-source Crystal Structure Prediction workflow based on machine learning interatomic potentials.<n>FastCSP consistently generates known experimental structures and ranks them within 5 kJ/mol per molecule of the global minimum.<n>Results demonstrate that universal MLIPs can be used across diverse compounds without requiring system-specific tuning.
  arXiv  Detail & Related papers  (2025-08-04T17:25:55Z)
• DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery [54.79763887844838]
  Large language models (LLMs) integrated with autonomous agents hold significant potential for advancing scientific discovery through automated reasoning and task execution.<n>We introduce DrugPilot, a LLM-based agent system with a parameterized reasoning architecture designed for end-to-end scientific in drug discovery.<n>DrugPilot significantly outperforms state-of-the-art agents such as ReAct and LoT, achieving task completion rates of 98.0%, 93.5%, and 64.0% for simple, multi-tool, and multi-turn scenarios, respectively.
  arXiv  Detail & Related papers  (2025-05-20T05:18:15Z)
• Leveraging Partial SMILES Validation Scheme for Enhanced Drug Design in Reinforcement Learning Frameworks [8.498666820216066]
  We propose Partial SMILES Validation-PPO (PSV-PPO), a novel RL algorithm that incorporates real-time partial SMILES validation to prevent catastrophic forgetting.<n>PSV-PPO performs stepwise validation at each auto-regressive step, evaluating not only the selected token candidate but also all potential branches stemming from the prior partial sequence.<n>Our experiments on the PMO and GuacaMol benchmark datasets demonstrate that PSV-PPO significantly reduces the number of invalid generated structures.
  arXiv  Detail & Related papers  (2025-05-01T13:57:20Z)
• LLM Agent Swarm for Hypothesis-Driven Drug Discovery [2.7036595757881323]
  PharmaSwarm is a unified multi-agent framework that orchestrates specialized "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds.<n>By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
  arXiv  Detail & Related papers  (2025-04-24T22:27:50Z)
• Accurate Ab-initio Neural-network Solutions to Large-Scale Electronic Structure Problems [52.19558333652367]
  We present finite-range embeddings (FiRE) for accurate large-scale ab-initio electronic structure calculations.<n>FiRE reduces the complexity of neural-network variational Monte Carlo (NN-VMC) by $sim ntextel$, the number of electrons.<n>We validate our method's accuracy on various challenging systems, including biochemical compounds and organometallic compounds.
  arXiv  Detail & Related papers  (2025-04-08T14:28:54Z)
• YZS-model: A Predictive Model for Organic Drug Solubility Based on Graph Convolutional Networks and Transformer-Attention [9.018408514318631]
  Traditional methods often miss complex molecular structures, leading to inaccuracies. We introduce the YZS-Model, a deep learning framework integrating Graph Convolutional Networks (GCN), Transformer architectures, and Long Short-Term Memory (LSTM) networks. YZS-Model achieved an $R2$ of 0.59 and an RMSE of 0.57, outperforming benchmark models.
  arXiv  Detail & Related papers  (2024-06-27T12:40:29Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• Integration of Domain Expert-Centric Ontology Design into the CRISP-DM for Cyber-Physical Production Systems [45.05372822216111]
  Methods from Machine Learning (ML) and Data Mining (DM) have proven to be promising in extracting complex and hidden patterns from the data collected. However, such data-driven projects, usually performed with the Cross-Industry Standard Process for Data Mining (CRISPDM), often fail due to the disproportionate amount of time needed for understanding and preparing the data. This contribution intends present an integrated approach so that data scientists are able to more quickly and reliably gain insights into the CPPS challenges.
  arXiv  Detail & Related papers  (2023-07-21T15:04:00Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions [80.12620331438052]
  deep learning has become an important tool for rapid screening of billions of molecules in silico for potential hits containing desired chemical features. Despite its importance, substantial challenges persist in training these models, such as severe class imbalance, high decision thresholds, and lack of ground truth labels in some datasets. We argue in favor of directly optimizing the receiver operating characteristic (ROC) in such cases, due to its robustness to class imbalance.
  arXiv  Detail & Related papers  (2020-06-25T08:46:37Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)
• Automated Deep Abstractions for Stochastic Chemical Reaction Networks [0.0]
  Low-level chemical reaction network (CRN) models give raise to a highly-dimensional continuous-time Markov chain (CTMC) A recently proposed abstraction method uses deep learning to replace this CTMC with a discrete-time continuous-space process. In this paper, we propose to further automatise deep abstractions for CRNs, through learning the optimal neural network architecture.
  arXiv  Detail & Related papers  (2020-01-30T13:49:58Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.